FDA Approves Omisirge Cell Therapy For Blood Cancers
18/4 07:17
(RTTNews) - The U.S. Food and Drug Administration approved Gamida Cell Ltd.'s Omisirge (omidubicel-onlv) cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation....